Flaig: It has been a remarkable 10 years for bladder cancer. If you think back to 10 or 15 years ago, we had no new ...

Cancer isn't a static target. Its genetic profile can change. So even with the newer targeted therapies, a patient's care ...

A common vitamin is drawing attention after researchers found it may significantly improve how patients respond to ...

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...

A man who was forced to travel 40 miles (64km) daily for cancer treatment has launched a campaign for his hospital to get its ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...

A new £2.6m radiotherapy machine has brought "improved reliability" to cancer treatment, a hospital said. Northampton General ...

BeOne’s subsidiary Guangzhou BeOne Medicines Biopharmaceutical signed a licensing agreement with Huahui Health to obtain the ...

Compass Therapeutics said its cancer treatment improved progression-free survival in a recent trial, but didn't meet its secondary endpoint in overall survival. Shares fell 23% to $3.85 in premarket ...

The death followed Grade 3 pneumonitis in a 66-year-old pancreatic cancer patient receiving a 24 mg dose. ・ERAS-0015 showed strong early tumor response rates, including 62% in KRAS-mutant lung cancer.

The Israeli leader had surgery in 2024 for an enlarged prostate. More recently, follow-up care detected a tumor, his office ...